Integrated Assessment of Inflammatory and Lipid–Metabolic Biomarkers in Psoriasis: Implications for Metabolic Syndrome
Life · 15.05.2026 · 16 (5) · 821
DOI: 10.3390/life16050821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 15.05.2026. Verfasst von Laura-Florina Nistor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oradea, Oradea, Romania.
Abstract (Originalsprache)
(1)
Background
Psoriasis is increasingly recognized as a systemic inflammatory disease associated with metabolic comorbidities. However, the hierarchical relationship between inflammatory activation and insulin resistance in driving metabolic syndrome (MetS) remains incompletely defined. This study aimed to characterize the integrated inflammatory–metabolic architecture of psoriasis using multivariate and latent domain modeling. (2)
Methods
In this cross-sectional hospital-based study (2020–2022), 235 adult patients with psoriasis were evaluated. Systemic inflammatory markers (NLR, SII, CRP, ESR) and composite metabolic indices (TyG, AIP, METS-IR) were assessed. Correlation analysis, multivariable linear and logistic regression, interaction modeling, and principal component analysis (PCA) were performed to examine independent associations and underlying domain structure. (3)
Results
Inflammatory and metabolic markers showed modest but significant correlations. In multivariable logistic regression, the TyG index was the strongest independent predictor of MetS (OR = 5.15, p < 0.001), whereas inflammatory markers did not retain independent significance. An interaction between adiposity and insulin resistance further improved model discrimination (AUC = 0.830). PCA identified two distinct latent domains explaining 69.9% of total variance: an immune–inflammatory domain (NLR, SII, ESR, CRP) and a metabolic–insulin resistance domain (TyG, AIP, METS-IR). Only the metabolic domain independently discriminated MetS. (4)
Conclusions
Psoriasis exhibits a multidimensional systemic architecture characterized by partially independent inflammatory and metabolic domains. Although systemic inflammation and metabolic dysfunction coexist, insulin-resistance-related indices were more strongly associated with metabolic syndrome in this cohort.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.
- Department of Pharmacology, Clinical Pharmacology and Pharmacotherapy, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.
- Department of Psycho-Neurosciences and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
ORCID-Profile: Laura-Florina Nistor, Ruxandra Cristina Marin, Delia Mirela Tit, Timea Claudia Ghitea
Förderung
- University of Oradea, Oradea, Romania
Zitieren
APA
Nistor, L. F., Marin, R. C., Tit, D. M., Bungau, G. S., Radu, A., Ghitea, T. C., Toma, M. M., & Endres, L. M. (2026). Integrated Assessment of Inflammatory and Lipid–Metabolic Biomarkers in Psoriasis: Implications for Metabolic Syndrome. Life, 16(5), 821. https://doi.org/10.3390/life16050821
Vancouver
Nistor LF, Marin RC, Tit DM, Bungau GS, Radu A, Ghitea TC, et al. Integrated Assessment of Inflammatory and Lipid–Metabolic Biomarkers in Psoriasis: Implications for Metabolic Syndrome. Life. 2026;16(5):821. doi:10.3390/life16050821
BibTeX
@article{Nistor2026,
author = {Nistor, Laura-Florina and Marin, Ruxandra Cristina and Tit, Delia Mirela and Bungau, Gabriela S and Radu, Ada and Ghitea, Timea Claudia and Toma, Mirela Marioara and Endres, Laura Maria},
title = {Integrated Assessment of Inflammatory and Lipid–Metabolic Biomarkers in Psoriasis: Implications for Metabolic Syndrome},
journal = {Life},
year = {2026},
volume = {16},
number = {5},
pages = {821},
doi = {10.3390/life16050821}
}
EUVIMED